OK - found my scraps of paper ...
If I take mid-point of profit guidance for FY18 ...
- 2H vs 1H FY18 - revenue down ~$1.4m, NPAT up ~$0.5m
- 2H18 vs 2H17 - revenue down ~$2.6m, NPAT down ~$1.0m
On this guidance, YOY revenue has gone backwards vs previous half and previous corresponding half. Previous half was good (but not extraordinary) considering past growth. So if I wanted to tell an OK news story, I'd avoid these comparisons and state the 'flat revenue' and 1-5% profit growth (as they did in the update). But ...
Revenue flattening/falling is a signal of a business maturing. I appreciate that they're wringing more profit out of the revenue (again a sign of a mature business) ... but a mature business doesn't trade on 20+ PE's (at today's reduced selling price). So, it's clear why the price fell. Without the statement about revenue growing in FY19, I think it would have fallen a lot more. But I'm now reading a bit more between the lines of the revenue fall (thanks as previously to Michael's post).
... but still skeptical and highly miffed about who knew what during the decline from $4 to $3 prior to the announcement!
- Forums
- ASX - By Stock
- IRI
- When to Catch a Falling Knife
When to Catch a Falling Knife, page-11
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
60.0¢ |
Change
0.015(2.56%) |
Mkt cap ! $104.7M |
Open | High | Low | Value | Volume |
61.0¢ | 61.0¢ | 58.5¢ | $182.5K | 303.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7209 | 59.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
60.0¢ | 6581 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2575 | 2.440 |
2 | 897 | 2.430 |
2 | 7887 | 2.420 |
2 | 2724 | 2.410 |
2 | 8724 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.450 | 5861 | 2 |
2.460 | 17285 | 6 |
2.470 | 724 | 1 |
2.480 | 22461 | 5 |
2.490 | 17590 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
IRI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online